Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
Revenue (Most Recent Fiscal Year) | $493.59M |
Net Income (Most Recent Fiscal Year) | $262.97M |
PE Ratio (Current Year Earnings Estimate) | 9.43 |
PE Ratio (Trailing 12 Months) | 9.17 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 6.42 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.58 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 8.76 |
Pre-Tax Margin (Trailing 12 Months) | 65.94% |
Net Margin (Trailing 12 Months) | 45.23% |
Return on Equity (Trailing 12 Months) | 16.84% |
Return on Assets (Trailing 12 Months) | 8.53% |
Current Ratio (Most Recent Fiscal Quarter) | 2.38 |
Quick Ratio (Most Recent Fiscal Quarter) | 2.38 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.99 |
Inventory Turnover (Trailing 12 Months) | -- |
Book Value per Share (Most Recent Fiscal Quarter) | $12.25 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.45 |
Earnings per Share (Most Recent Fiscal Year) | $2.00 |
Diluted Earnings per Share (Trailing 12 Months) | $1.33 |
Exchange | NYSE |
Sector | Financial Services |
Industry | Asset Management |
Common Shares Outstanding | 175.43M |
Free Float | 172.09M |
Market Capitalization | $3.15B |
Average Volume (Last 20 Days) | 1.10M |
Beta (Past 60 Months) | 0.94 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 1.90% |
Percentage Held By Institutions (Latest 13F Reports) | 19.69% |
Annual Dividend (Based on Last Quarter) | $1.60 |
Dividend Yield (Based on Last Quarter) | 8.90% |